Ad
related to: Vaccine 12-15- Schedule A Vaccine
Book A Vaccine Appointment
Today At A Location Near You.
- Take Eligibility Quiz
Check Your Eligibility For Vaccines
That May Help Protect You.
- Pneumococcal Pneumonia
Visit VaxAssist.com To
See If You Are Eligible.
- Questions About Cost?
Visit To Find More Information
On COVID-19 Vaccination Costs.
- Schedule A Vaccine
Search results
7 Penny Biotech Stocks to Triple Your Investment
InvestorPlace via Yahoo Finance· 7 days agoOne of the oldest maxims in investing is that higher risk produces greater returns. That maxim holds particularly true across penny biotech stocks....
Millions of Older Americans are Already Benefitting from AARP-Supported Drug Law
AARP· 5 days agoAs we take time to acknowledge the contributions of past and current older persons during Older Americans Month, a new law passed in 2022 is lowering the prices of prescription drugs and creating ...
Is Pfizer the Best Dividend Stock for You?
The Motley Fool via AOL· 3 days agoManagement is forecasting full-2024 sales at between $58.5 billion and $61.5 billion, notably higher than trailing 12-month sales of $55 billion. In...
Takeaways from Tallahassee — It’s prep time
Florida Politics· 3 days agoAnother disaster preparedness sales tax holiday will run from Aug. 24 through Sept. 6. The holidays were part of the tax cut package (HB 7073) signed by...
Obesity Drug Stocks: Where to Invest Now
Morningstar· 6 days agoPharmaceutical investing has seen huge moves in the industry’s stocks over the past year, with one area grabbing particular attention: obesity drugs....
Column: Is UCLA a 'failed medical school'? Debunking a dumb right-wing meme
Los Angeles Times· 4 days agoThe right-wing and Republican project to eradicate diversity and inclusiveness from American society...
Accelerated Approval Process Is Not Without Risk: Placing Recent FDA Action in Context | JD Supra
JD Supra· 7 days agoOn February 23, the Food and Drug Administration (FDA) withdrew approval of Pepaxto (melphalan flufenamide), a drug that it had previously granted accelerated approval for treatment of multiple ...
Reasons to Retain Baxter International (BAX) in Your Portfolio Now
Zacks via Yahoo Finance· 6 days agoBaxter International's (BAX) robust growth across all geographies, along with transformational...
Forbes Daily: Nvidia Within Striking Distance Of Surpassing Apple
Forbes· 5 days agoThe concept of the luxury traveler, which a new McKinsey report defines as someone who spends at...
AstraZeneca CEO Has No Plans to Retire as He Seeks to Nearly Double Sales by 2030
The Wall Street Journal· 3 days agoAstraZeneca’s longest-serving chief executive, Pascal Soriot, has no plans to step down for now as...